Impact of Vendor Systems on Ambulatory Medication Safety (BWHCERT5E)

February 27, 2012 updated by: Weill Medical College of Cornell University
Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Fishkill, New York, United States, 12524
        • Taconic IPA
      • New York, New York, United States, 10038
        • New York City Department of Health and Mental Hygiene

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Our study will take place in 2 NYS communities. We will select 2 communities in order to assemble a study population with the following characteristics: use of at least 2 different vendor-based systems, different implementation times (with some communities being early adopters and others experienced users), and inclusion of urban underserved and federally defined rural areas.

We will select the following 2 communities/organizations: the community health centers implementing electronic prescribing with the New York City Department of Health (NYC DOH) and the Taconic Health Information Network and Community (THINC) in the Hudson Valley of New York. Both communities have expressed their interest in participating in this study.

Description

Inclusion Criteria:

  • >=0.75 FTE providers

Exclusion Criteria:

  • <0.75 FTE providers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Providers adopting electronic prescribing in New York City, New York
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
2
Providers adopting electronic prescribing in the Taconic region of New York
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
prescribing error
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
near misses
Time Frame: 1 year
1 year
preventable adverse drug events
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Weill Medical College of Cornell University

Collaborators

Agency for Healthcare Research and Quality (AHRQ)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2008

Primary Completion (ACTUAL)

July 1, 2011

Study Completion (ACTUAL)

October 1, 2011

Study Registration Dates

First Submitted

October 3, 2008

First Submitted That Met QC Criteria

October 15, 2008

First Posted (ESTIMATE)

October 16, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

February 28, 2012

Last Update Submitted That Met QC Criteria

February 27, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • U18HS0169705E

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medication Errors

Clinical Trials on Electronic prescribing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe